Viewing Study NCT03983161


Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2026-01-25 @ 12:58 AM
Study NCT ID: NCT03983161
Status: COMPLETED
Last Update Posted: 2023-03-17
First Post: 2019-06-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment
Sponsor: Celgene
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FEDR-CP-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View